Updates matching "National"

A new survey offers insight into how a national paid family and medical leave program could benefit cancer patients and survivors who struggle with missed work and lost income due to their illness.

Washington, D.C. – The U.S. District Court in the Southern District of California will hear oral arguments Thursday in a lawsuit brought by the African American Tobacco Control Leadership Council (AATCLC), Action on Smoking and Health (ASH) and the American Medical Association (AMA), claiming that the Food and Drug Administration’s

More than 150 organizations representing patients, providers and health equity advocates sent a letter to Congress today urging them to pass the Diversifying Investigations Via Equitable Research Studies for Everyone (DIVERSE) Trials Act into law.

On behalf of the millions of patients and caregivers we represent, we applaud House lawmakers for listening to their constituents and taking action to amend the Build Back Better legislation to include the creation of a paid medical and family leave program

As negotiations continue and details emerge regarding budget reconciliation legislation, patient and caregiver groups are gravely concerned that a national paid family and medical leave program has been dropped from the package.

A new survey shows cancer patients and recent survivors have had a positive experience using telehealth in the wake of the pandemic and are willing to use or adapt to using telehealth services in the future.

As Congress prepares to consider the Build Back Better Act , cancer patients, survivors and their caregivers are urging lawmakers to make sure certain key health provisions are included in any final legislation.

As lawmakers deliberate which health care priorities to include in the budget reconciliation package, ACS CAN is strongly urging Congress and the Administration to once and for all permanently close the Medicaid coverage gap and provide access to quality, affordable coverage to millions of Americans.

ACS CAN President Lisa Lacasse expresses concern over FDA's approval of four flavored tobacco products.